Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jacobsen

Showing results (301-310 of 372) with videos related to

Pageof 38
Sort By:
Inflammatory Bowel Diseases|August 31, 2010
Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control studyVibeke Andersen, Elaine Nimmo, Henrik B Krarup, et al.
Scandinavian Journal of Gastroenterology|September 27, 2008
Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish populationMette Østergaard, Anja Ernst, Rodrigo Labouriau, et al.
Respiratory Research|May 13, 2021
Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employmentPeter A Jacobsen, Alex J van 't Hul, Remco S Djamin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacyN R Mirza, J S Larsen, C Mathiasen, et al.
ERJ Open Research|January 6, 2023
All-cause admissions following a first ever exacerbation-related hospitalisation in COPDKiki Waeijen-Smit, Peter A Jacobsen, Sarah Houben-Wilke, et al.
Acta Physiologica (Oxford, England)|September 22, 2018
The acute blood pressure-lowering effect of amiloride is independent of endothelial ENaC and eNOS in humans and miceRikke Ydegaard, Henrik Andersen, Christina S Oxlund, et al.
Oncoimmunology|January 18, 2021
Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associationsSharon Grisaru-Tal, Michal Itan, Daniel G Grass, et al.
European Journal of Pharmacology|April 9, 2013
Characterization of a novel high-potency positive modulator of K(v)7 channelsWilliam Dalby-Brown, Carsten Jessen, Charlotte Hougaard, et al.
AJNR. American Journal of Neuroradiology|July 11, 2015
Single-Layer WEBs: Intrasaccular Flow Disrupters for Aneurysm Treatment—Feasibility Results from a European StudyJ Caroff, C Mihalea, J Klisch, et al.
Ugeskrift for Laeger|February 10, 1997
[Euricterus. A European database on icterus with emphasis on the Danish contribution]G Jørgensen, I B Anderson, E Black, et al.
Pageof 38

Showing results (301-310 of 372) with videos related to

Sort By:
Pageof 38
Inflammatory Bowel Diseases|August 31, 2010
Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control studyVibeke Andersen, Elaine Nimmo, Henrik B Krarup, et al.
Scandinavian Journal of Gastroenterology|September 27, 2008
Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish populationMette Østergaard, Anja Ernst, Rodrigo Labouriau, et al.
Respiratory Research|May 13, 2021
Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employmentPeter A Jacobsen, Alex J van 't Hul, Remco S Djamin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacyN R Mirza, J S Larsen, C Mathiasen, et al.
ERJ Open Research|January 6, 2023
All-cause admissions following a first ever exacerbation-related hospitalisation in COPDKiki Waeijen-Smit, Peter A Jacobsen, Sarah Houben-Wilke, et al.
Acta Physiologica (Oxford, England)|September 22, 2018
The acute blood pressure-lowering effect of amiloride is independent of endothelial ENaC and eNOS in humans and miceRikke Ydegaard, Henrik Andersen, Christina S Oxlund, et al.
Oncoimmunology|January 18, 2021
Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associationsSharon Grisaru-Tal, Michal Itan, Daniel G Grass, et al.
European Journal of Pharmacology|April 9, 2013
Characterization of a novel high-potency positive modulator of K(v)7 channelsWilliam Dalby-Brown, Carsten Jessen, Charlotte Hougaard, et al.
AJNR. American Journal of Neuroradiology|July 11, 2015
Single-Layer WEBs: Intrasaccular Flow Disrupters for Aneurysm Treatment—Feasibility Results from a European StudyJ Caroff, C Mihalea, J Klisch, et al.
Ugeskrift for Laeger|February 10, 1997
[Euricterus. A European database on icterus with emphasis on the Danish contribution]G Jørgensen, I B Anderson, E Black, et al.
Pageof 38